Responsible Commercialization of Deep Tech in Healthcare is Premised on TRUST
Updated March 3, 2023
A video we’d like to share with you presents a speech by Michelle Perugini, CEO & Founder at Presagen. Michelle talks about the Responsible Commercialization of Deep Tech in Healthcare is Premised on TRUST.
Topic – Responsible Commercialization of Deep Tech in Healthcare is Premised on TRUST
- Integration of deep tech into clinical practice like AI relies on TRUST
- TRUST is premised on: data and technology, scientific and clinical validation, regulatory and quality management, clinical utility, patient benefit, and cost vs value
- How can we drive responsible introduction of AI into clinical practice
- How can we overcome issues of TRUST to drive a harmonious relationship between AI and clinicians
About speaker
Dr. Michelle Perugini is a health tech entrepreneur with extensive experience in healthcare and advanced AI technologies. Michelle is an avid supporter of the AI and women’s health sectors globally, and Winner of the 2021 Women in AI (WAI) Healthcare Award. She has a PhD in Medicine and was a post-doctoral research fellow in Oncology for a decade. She has founded 2 global AI tech companies, the first of which was acquired by EY in 2015. Michelle is currently Co-Founder and CEO of Presagen, an AI healthcare company building The Social Network for Healthcare, with a focus in Women’s Health. Presagen’s first product Life Whisperer uses AI for embryo selection to improve pregnancy outcomes in IVF, and is being used in IVF clinics globally.
You can get the full recording of the HealthTech 2022-2023 Summit here.
